| Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single … ME Sarasquete, R García-Sanz, L Marin, M Alcoceba, MC Chillón, ... Blood, The Journal of the American Society of Hematology 112 (7), 2709-2712, 2008 | 272 | 2008 |
| Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting LI Sánchez-Abarca, S Gutierrez-Cosio, C Santamaría, ... Blood, The Journal of the American Society of Hematology 115 (1), 107-121, 2010 | 256 | 2010 |
| Isolation and characterization of mesenchymal stromal cells from human degenerated nucleus pulposus: comparison with bone marrow mesenchymal stromal cells from the same subjects JF Blanco, IF Graciani, FM Sanchez-Guijo, S Muntión, ... Spine 35 (26), 2259-2265, 2010 | 244 | 2010 |
| Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors M Garayoa, JL Garcia, C Santamaría, A García-Gómez, JF Blanco, ... Leukemia 23 (8), 1515-1527, 2009 | 158 | 2009 |
| Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia CM Santamaría, MC Chillón, R García-Sanz, C Perez, MD Caballero, ... Blood, The Journal of the American Society of Hematology 114 (1), 148-152, 2009 | 131 | 2009 |
| Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians MR Betts, J Krowka, C Santamaria, K Balsamo, F Gao, G Mulundu, C Luo, ... Journal of virology 71 (11), 8908-8911, 1997 | 130 | 1997 |
| Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients C Santamaría, S Muntión, B Rosón, B Blanco, O López-Villar, S Carrancio, ... haematologica 97 (8), 1218, 2012 | 109 | 2012 |
| Using quantification of the PML-RARα transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia C Santamaría, MC Chillón, C Fernández, P Martín-Jiménez, ... Haematologica 92 (3), 315-322, 2007 | 94 | 2007 |
| Dasatinib as a bone-modifying agent: anabolic and anti-resorptive effects A Garcia-Gomez, EM Ocio, E Crusoe, C Santamaria, ... PloS one 7 (4), e34914, 2012 | 77 | 2012 |
| Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population B Blanco, JA Pérez-Simón, LI Sánchez-Abarca, T Caballero-Velazquez, ... haematologica 94 (7), 975, 2009 | 74 | 2009 |
| High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics CM Santamaría, MC Chillón, R García-Sanz, C Pérez, MD Caballero, ... Leukemia research 33 (12), 1706-1709, 2009 | 68 | 2009 |
| BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML) C Santamaría, MC Chillón, R García-Sanz, C Pérez, MD Caballero, ... Annals of hematology 89, 453-458, 2010 | 66 | 2010 |
| The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia C Santamaría, M Chillón, R García-Sanz, A Balanzategui, ME Sarasquete, ... Ferrata Storti Foundation, 2008 | 66 | 2008 |
| Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients MC Chillón, C Santamaría, R García-Sanz, A Balanzategui, SM Eugenia, ... haematologica 95 (5), 745, 2010 | 52 | 2010 |
| Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens B Blanco, LI Sánchez-Abarca, T Caballero-Velázquez, C Santamaría, ... Leukemia research 35 (10), 1412-1415, 2011 | 37 | 2011 |
| Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment S Gutierrez-Cosio, L de la Rica, E Ballestar, C Santamaría, ... Leukemia research 36 (7), 895-899, 2012 | 28 | 2012 |
| Frequency of HLA‐A,‐B and‐DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest‐central Spain) M Alcoceba, L Marin, A Balanzategui, ME Sarasquete, MC Chillon, ... Tissue Antigens 78 (4), 249-255, 2011 | 20 | 2011 |
| Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in … C Santamaría, F Ramos, N Puig, E Barragán, R de Paz, C Pedro, ... Annals of hematology 91, 1887-1895, 2012 | 19 | 2012 |
| Prospective comparative analysis of the angiogenic capacity of monocytes and CD133+ cells in a murine model of hind limb ischemia N López-Holgado, M Alberca, FM Sánchez-Guijo, EM Villarón, JV Rivas, ... Cytotherapy 11 (8), 1041-1051, 2009 | 13 | 2009 |
| N. N′ Gandu, H. Sheppard, BH Hahn, S. Allen, and JA Frelinger. 1997. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected … MR Betts, J Krowka, C Santamaria, K Balsamo, F Gao, G Mulundu, C Luo J. Virol 71, 8908-8911, 0 | 10 | |
